About Xcene Research
Xcene Research is a leading indigenous African Contract Research Organization (CRO) providing full-service support to pharmaceutical, biotechnology, and medical device companies, as well as academic institutions.
We offer a range of services that help companies take new products from discovery through to market, with a specific focus on emerging markets across Sub-Saharan Africa. Our expertise spans the management, execution, and analysis of clinical trials from Phase I through Phase IV, covering both small-scale and complex global programs and bioavailability/bioequivalence studies.
In addition to our CRO capabilities, Xcene Research is actively engaged in Drug Discovery, supporting early-stage research, preclinical studies, and translational research. This dual capability allows us to provide end-to-end R&D services, positioning Africa as a contributor to global health innovation and ensuring that therapies are relevant to the continent’s unique disease burdens.
Trust is one of our core values. We uphold it through on-time delivery, uncompromising quality, transparent communication, and complete visibility into project status. These values guide our interactions with sponsors, regulators, and health communities alike.
As a pioneer in the Sub-Saharan African market, Xcene Research combines therapeutic expertise, internal capacity, and financial stability to deliver cost-effective, world-class services.
Headquartered in Lagos, Nigeria, we are committed to building strategic partnerships worldwide and advancing Africa’s role in global clinical research and drug innovation.
